THE CODI Co (224060) Fair Value & Analysis
Technology · KR · Market cap 19.6B KRW
Fair value as of: Jul 7, 2026
From 10 valuation models · updated today
Fair value updated Jul 7, 2026 — revised from 69,365 KRW to 5,888 KRW (−91.5%) since Jun 24, 2026. Share price +17.0% over the past month.
Price vs Fair Value (12 months)
12‑month range 2,430 KRW – 7,110 KRW · fair‑value band 4,416 KRW – 8,267 KRW · the 4,680 KRW price screens below the 5,888 KRW fair value. As of Jul 7, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
THE CODI Co (224060) currently trades at 4,680 KRW, while our model-based Fair Value estimate is 5,888 KRW — implying the stock looks roughly 25.8% undervalued today. We read business quality at 51/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Trailing-twelve-month revenue stands at 23.5B KRW. Revenue declined 25.5% year over year. It earns a return on equity of -72.1%. Net debt stands at 44.7B KRW. Fundamentals as of Jul 7, 2026
Our scenario range runs from 4,416 KRW (bear case) to 8,267 KRW (bull case); at 4,680 KRW, the current price sits within that range. The share trades about 37% below its 52-week high and 95% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -74% fair-value upside — at 26%, 224060 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 7, 2026. TTM = trailing twelve months.
About the company
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
THE CODI Co reported revenue of 25.3B KRW in FY2025 versus 45.4B KRW in FY2021, a compound −13.6%/yr. Reported net income was 24.3B KRW in FY2025.
Is 224060 fairly valued? → Check now
Similar stocks
10 more Semiconductor Equipment & Materials stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| ASML Holding ASMLF | $1,924 | $508.47 | -74% |
| Applied Materials, Inc AMAT | C$66.36 | C$16.00 | -76% |
| Lam Research Corporation LRCX | $303.28 | $101.48 | -67% |
| KLA Corporation KLAC | $2,136 | $742.75 | -65% |
| Tokyo Electron Limited TOELF | $443.58 | $117.43 | -74% |
| Advantest Corporation ATEYY | $195.62 | $83.32 | -57% |
| NAURA Technology Group 002371 | ¥745.00 | ¥88.30 | -88% |
| Hon. Precision, Inc 7769 | 7,055 TWD | 2,405 TWD | -66% |
| Advanced Micro-Fabrication Equipment Inc 688012 | ¥276.00 | ¥68.99 | -75% |
| Hangzhou Changchuan Technology Co 300604 | ¥226.74 | ¥33.33 | -85% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is THE CODI Co (224060) undervalued?
What is the fair value of 224060?
What is the quality score of 224060?
What is the revenue of THE CODI Co (224060)?
What is the net profit margin of 224060?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.